Lawrence H. Schwartz

87.3k total citations · 15 hit papers
395 papers, 52.0k citations indexed

About

Lawrence H. Schwartz is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Lawrence H. Schwartz has authored 395 papers receiving a total of 52.0k indexed citations (citations by other indexed papers that have themselves been cited), including 196 papers in Radiology, Nuclear Medicine and Imaging, 160 papers in Pulmonary and Respiratory Medicine and 116 papers in Oncology. Recurrent topics in Lawrence H. Schwartz's work include Radiomics and Machine Learning in Medical Imaging (140 papers), Hepatocellular Carcinoma Treatment and Prognosis (65 papers) and Medical Imaging Techniques and Applications (64 papers). Lawrence H. Schwartz is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (140 papers), Hepatocellular Carcinoma Treatment and Prognosis (65 papers) and Medical Imaging Techniques and Applications (64 papers). Lawrence H. Schwartz collaborates with scholars based in United States, France and Canada. Lawrence H. Schwartz's co-authors include Lalitha Shankar, Janet Dancey, Jan Bogaerts, Stephen J. Gwyther, Larry Rubinstein, Daniel J. Sargent, Lori E. Dodd, Denis Lacombe, P. Therasse and Richard Kaplan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nature reviews. Cancer.

In The Last Decade

Lawrence H. Schwartz

377 papers receiving 51.1k citations

Hit Papers

New response evaluation c... 1999 2026 2008 2017 2008 2014 2018 2017 2016 5.0k 10.0k 15.0k 20.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
    2008 20.7k citations Jan Bogaerts, Lawrence H. Schwartz et al. profile →
  2. Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
    2014 3.2k citations Bruce D. Cheson, Lawrence H. Schwartz et al. Journal of Clinical Oncology profile →
  3. Artificial intelligence in radiology
    2018 2.3k citations Ahmed Hosny, Chintan Parmar et al. Nature reviews. Cancer profile →
  4. iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
    2017 1.5k citations Lesley Seymour, Jan Bogaerts et al. The Lancet Oncology profile →
  5. RECIST 1.1—Update and clarification: From the RECIST committee
    2016 1.2k citations Lawrence H. Schwartz, Saskia Litière et al. profile →
  6. Artificial intelligence in cancer imaging: Clinical challenges and applications
    2019 1.2k citations Ahmed Hosny, Lawrence H. Schwartz et al. profile →
  7. Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
    2014 989 citations Lale Kostakoğlu, Lawrence H. Schwartz et al. Journal of Clinical Oncology profile →
  8. Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma
    2007 967 citations Malik E. Juweid, Sigrid Stroobants et al. Journal of Clinical Oncology profile →
  9. Phase II Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma
    2006 948 citations Lawrence H. Schwartz et al. Journal of Clinical Oncology profile →
  10. Intrahepatic Cholangiocarcinoma
    2008 646 citations Mithat Gönen, Adam C. Yopp et al. profile →
  11. Prognostic Factors for Survival in Previously Treated Patients With Metastatic Renal Cell Carcinoma
    2004 609 citations Robert J. Motzer, Lawrence H. Schwartz et al. Journal of Clinical Oncology profile →
  12. Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation
    1999 487 citations Lawrence H. Schwartz et al. profile →
  13. Reproducibility of radiomics for deciphering tumor phenotype with imaging
    2016 412 citations Binsheng Zhao, Lin Lü et al. profile →
  14. Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone
    2016 271 citations Mithat Gönen, Constantinos T. Sofocleous et al. Journal of Clinical Oncology profile →
  15. Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE‐MRI derived biomarkers in multicenter oncology trials
    2018 252 citations Lawrence H. Schwartz et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lawrence H. Schwartz United States 80 21.2k 20.6k 16.5k 8.4k 6.9k 395 52.0k
Richard Kaplan United Kingdom 48 22.4k 1.1× 20.2k 1.0× 7.5k 0.5× 7.8k 0.9× 3.9k 0.6× 173 46.0k
Larry Rubinstein United States 54 22.4k 1.1× 20.2k 1.0× 7.4k 0.4× 7.3k 0.9× 3.0k 0.4× 196 47.6k
Mithat Gönen United States 119 26.5k 1.3× 19.4k 0.9× 8.6k 0.5× 20.8k 2.5× 3.7k 0.5× 781 60.7k
Daniel J. Sargent United States 89 37.1k 1.8× 17.9k 0.9× 5.5k 0.3× 12.3k 1.5× 11.6k 1.7× 477 57.7k
Susan G. Arbuck United States 41 21.8k 1.0× 16.5k 0.8× 6.4k 0.4× 6.9k 0.8× 2.9k 0.4× 88 40.5k
Janet Dancey United States 68 19.9k 0.9× 15.4k 0.7× 5.4k 0.3× 5.5k 0.7× 3.3k 0.5× 205 38.3k
Denis Lacombe Belgium 34 15.2k 0.7× 14.2k 0.7× 7.1k 0.4× 4.7k 0.6× 2.2k 0.3× 113 41.0k
Elizabeth A. Eisenhauer Canada 61 15.2k 0.7× 12.7k 0.6× 5.4k 0.3× 4.1k 0.5× 2.8k 0.4× 213 41.9k
Jaap Verweij Netherlands 100 28.2k 1.3× 22.3k 1.1× 3.6k 0.2× 8.8k 1.0× 4.6k 0.7× 621 55.4k
Jürgen Debus Germany 94 12.4k 0.6× 19.8k 1.0× 12.6k 0.8× 8.8k 1.0× 1.6k 0.2× 1.3k 43.7k

Countries citing papers authored by Lawrence H. Schwartz

Since Specialization
Citations

This map shows the geographic impact of Lawrence H. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence H. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence H. Schwartz more than expected).

Fields of papers citing papers by Lawrence H. Schwartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence H. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence H. Schwartz. The network helps show where Lawrence H. Schwartz may publish in the future.

Co-authorship network of co-authors of Lawrence H. Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence H. Schwartz. A scholar is included among the top collaborators of Lawrence H. Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence H. Schwartz. Lawrence H. Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zadeh, Mahdi Zirakchian, Vlasios S. Sotirchos, Assen S. Kirov, et al.. (2024). Three-Dimensional Margin as a Predictor of Local Tumor Progression after Microwave Ablation: Intraprocedural versus 4–8-Week Postablation Assessment. Journal of Vascular and Interventional Radiology. 35(4). 523–532.e1. 12 indexed citations
2.
Schöffski, Patrick, Patricia LoRusso, Nobuyuki Yamamoto, et al.. (2024). 56O A phase Ia/Ib study of the MDM2-p53 antagonist brigimadlin (BI 907828): Safety and efficacy in patients with dedifferentiated liposarcoma. ESMO Open. 9. 102446–102446. 3 indexed citations
3.
Khalil, David, Samy Ammari, Egesta Lopci, et al.. (2023). Recent Advances in the Field of Artificial Intelligence for Precision Medicine in Patients with a Diagnosis of Metastatic Cutaneous Melanoma. Diagnostics. 13(22). 3483–3483. 3 indexed citations
4.
Leighl, Natasha B., Mary W. Redman, Naiyer A. Rizvi, et al.. (2021). Phase II study of durvalumab plus tremelimumab as therapy for patients with previously treated anti-PD-1/PD-L1 resistant stage IV squamous cell lung cancer (Lung-MAP substudy S1400F, NCT03373760). Journal for ImmunoTherapy of Cancer. 9(8). e002973–e002973. 38 indexed citations
5.
Dercle, Laurent, Matthew Fronheiser, Lin Lü, et al.. (2020). Identification of Non–Small Cell Lung Cancer Sensitive to Systemic Cancer Therapies Using Radiomics. Clinical Cancer Research. 26(9). 2151–2162. 128 indexed citations
6.
Maitland, Michael L., Julia Wilkerson, Binsheng Zhao, et al.. (2020). Enhanced Detection of Treatment Effects on Metastatic Colorectal Cancer with Volumetric CT Measurements for Tumor Burden Growth Rate Evaluation. Clinical Cancer Research. 26(24). 6464–6474. 26 indexed citations
7.
Schöder, Heiko, Mei‐Yin C. Polley, Michael V. Knopp, et al.. (2020). Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial. Blood. 135(25). 2224–2234. 63 indexed citations
8.
9.
Hosny, Ahmed, Chintan Parmar, John Quackenbush, Lawrence H. Schwartz, & Hugo J.W.L. Aerts. (2018). Artificial intelligence in radiology. Nature reviews. Cancer. 18(8). 500–510. 2301 indexed citations breakdown →
10.
Seymour, Lesley, Jan Bogaerts, Andrea Perrone, et al.. (2017). iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. The Lancet Oncology. 18(3). e143–e152. 1528 indexed citations breakdown →
11.
Zabor, Emily C., Glenn Heller, Lawrence H. Schwartz, & Paul B. Chapman. (2015). Correlating Surrogate Endpoints with Overall Survival at the Individual Patient Level in BRAFV600E-Mutated Metastatic Melanoma Patients Treated with Vemurafenib. Clinical Cancer Research. 22(6). 1341–1347. 6 indexed citations
12.
Gollub, Marc J., Kun Cao, David H. Gültekin, et al.. (2013). Prognostic Aspects of DCE-MRI in Recurrent Rectal Cancer. European Radiology. 23(12). 3336–3344. 13 indexed citations
13.
Oxnard, Geoffrey R., Binsheng Zhao, Camelia S. Sima, et al.. (2011). Variability of Lung Tumor Measurements on Repeat Computed Tomography Scans Taken Within 15 Minutes. Journal of Clinical Oncology. 29(23). 3114–3119. 118 indexed citations
14.
Yopp, Adam C., Lawrence H. Schwartz, Nancy E. Kemeny, et al.. (2011). Antiangiogenic Therapy for Primary Liver Cancer: Correlation of Changes in Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Tissue Hypoxia Markers and Clinical Response. Annals of Surgical Oncology. 18(8). 2192–2199. 66 indexed citations
15.
Zhao, Binsheng, Geoffrey R. Oxnard, Chaya S. Moskowitz, et al.. (2010). A Pilot Study of Volume Measurement as a Method of Tumor Response Evaluation to Aid Biomarker Development. Clinical Cancer Research. 16(18). 4647–4653. 82 indexed citations
16.
Danila, Daniel C., Michael J. Morris, Johann S. de Bono, et al.. (2010). Phase II Multicenter Study of Abiraterone Acetate Plus Prednisone Therapy in Patients With Docetaxel-Treated Castration-Resistant Prostate Cancer. Journal of Clinical Oncology. 28(9). 1496–1501. 318 indexed citations
17.
Juweid, Malik E., Sigrid Stroobants, Otto S. Hoekstra, et al.. (2007). Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. Journal of Clinical Oncology. 25(5). 571–578. 967 indexed citations breakdown →
18.
Morris, Michael J., Jean T. Santamauro, Jinru Shia, et al.. (2002). Fatal respiratory failure associated with treatment of prostate cancer using docetaxel and estramustine. Urology. 60(6). 1111–1111. 14 indexed citations
19.
Motzer, Robert J., Ashok Rakhit, John A. Thompson, et al.. (2001). Randomized Multicenter Phase II Trial of Subcutaneous Recombinant Human Interleukin-12 Versus Interferon-α2a for Patients with Advanced Renal Cell Carcinoma. Journal of Interferon & Cytokine Research. 21(4). 257–263. 83 indexed citations
20.
Schwartz, Lawrence H., et al.. (2001). Conducting Web-Based Surveys: Keys to Success. 30(2). 47. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Kaplan Breakdown of academic impact, for papers by Larry Rubinstein Breakdown of academic impact, for papers by Mithat Gönen Breakdown of academic impact, for papers by Daniel J. Sargent Breakdown of academic impact, for papers by Susan G. Arbuck Breakdown of academic impact, for papers by Janet Dancey Breakdown of academic impact, for papers by Denis Lacombe Breakdown of academic impact, for papers by Elizabeth A. Eisenhauer Breakdown of academic impact, for papers by Jaap Verweij Breakdown of academic impact, for papers by Jürgen Debus
Rankless by CCL
2026